Verition Fund Management
DMAAR

Verition Fund Management’s Drugs Made In America Acquisition Corp Rights DMAAR Stock Holding History

Verition Fund Management’s Portfolio DMAAR Stock Details DMAAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-99,200
Closed -$5.47K – 2628
2026
Q1 		$5.47K Sell
99,200
-800
-0.8% -$85 ﹤0.01% 2182
2025
Q4 		$15.8K Hold
100,000
– – ﹤0.01% 3431
2025
Q3 		$21.8K Hold
100,000
– – ﹤0.01% 3690
2025
Q2 		$12.5K Buy
+100,000
New +$12.9K ﹤0.01% 3578

Other funds holding DMAAR

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
AGM
Alpine Global Management New York $615M AUM 34.28% 1-Year Est. Return

Verition Fund Management's DMAAR Position: Q2 2026 in Review

Verition Fund Management sold out of Drugs Made In America Acquisition Corp Rights (DMAAR) in Q2 2026, closing a stake of 99,200 shares — an estimated $5.47K sold.

Verition Fund Management first reported a position in DMAAR in Q2 2025 and held it in 4 quarters. The position peaked at $21.8K in Q3 2025. 28 funds tracked by Wall St. Rank hold DMAAR as of Q2 2026.

  • Verition Fund Management reported no remaining Drugs Made In America Acquisition Corp Rights position as of Q2 2026 after selling out during the quarter.
  • Verition Fund Management sold 99,200 Drugs Made In America Acquisition Corp Rights shares in Q2 2026, an estimated $5.47K.
  • Verition Fund Management first reported a position in Drugs Made In America Acquisition Corp Rights in Q2 2025 and held it in 4 quarters.
  • Verition Fund Management's Drugs Made In America Acquisition Corp Rights position peaked at $21.8K in Q3 2025.
  • 28 funds tracked by Wall St. Rank held Drugs Made In America Acquisition Corp Rights as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.